Clinical trial
Retrospective Clinical Study of COVID-19 Associated With the Condition and Treatment of Patients With Chinese Psoriasis
NCT05961605 is registered in ClinicalTrials.gov with Gang Wang, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Clinical Study of COVID-19 Associated With the Condition and Treatment of Patients With Chinese Psoriasis
- Lead sponsor
- Gang Wang, MD
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 15, 2023
- Completion date
- July 30, 2023
- Enrollment
- 2,500 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, psoriasis patients